Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.62 |
| ▸ | MAOB | P27338 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8492933 | 0.80 | MAOA (0.44) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL5808750 | 0.79 | MAOA (0.42) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL521775 | 0.78 | MAOA (1.00) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL29419966 | 0.78 | MAOA (1.00) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL7161766 | 0.76 | MAOA (0.35) | MAOAMAOBCYP2C9KMT2AMEN1 | |
| SCHEMBL28681589 | 0.76 | MAOA (0.95) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL22615 | 0.76 | CYP2C9 (0.42) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL7840975 | 0.72 | KMT2A (0.35) | MAOAMAOBHDAC3HDAC4HDAC7 | |
| SCHEMBL2721424 | 0.70 | MAOA (0.74) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL2796781 | 0.68 | HTR2A (0.42) | MAOAMAOBHDAC4HDAC7HDAC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2528921-A2 | 7-AZONIABICYCLO [2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | Theron Pharmaceuticals, Inc. (US) | 2012-12-05 | — | — | EP | claimed |
| US-20120029044-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS INC. | 2012-02-02 | — | — | US | claimed |
| WO-2011094434-A2 | 7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS, INC. (US) | 2011-08-04 | — | — | WO | claimed |
| CN-104744480-B | 7-azoniabicyclo [2.2.1] heptane derivatives, process for their preparation, and their pharmaceutical use | 西伦制药公司 | 2021-02-12 | — | — | CN | disclosed |
| EP-2528921-B1 | 7-AZONIABICYCLO [2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS INC (US) | 2017-10-18 | — | — | EP | disclosed |
| US-20160296497-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS, INC. | 2016-10-13 | — | — | US | disclosed |
| US-9320731-B2 | 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof | THERON PHARMACEUTICALS, INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140249195-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS, INC (US) | 2014-09-04 | — | — | US | disclosed |
| US-8742134-B2 | 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof | THERON PHARMACEUTICALS, INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-8742131-B2 | 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof | THERON PHARMACEUTICALS, INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-20130157989-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS, INC. (US) | 2013-06-20 | — | — | US | disclosed |
| US-8426611-B2 | 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof | THERON PHARMACEUTICALS INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20130059898-A1 | 7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS, INC. (US) | 2013-03-07 | — | — | US | disclosed |
| EP-2528921-A2 | 7-AZONIABICYCLO [2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | Theron Pharmaceuticals, Inc. (US) | 2012-12-05 | — | — | EP | disclosed |
| US-20120029044-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS INC. | 2012-02-02 | — | — | US | disclosed |
| WO-2011094434-A2 | 7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | THERON PHARMACEUTICALS, INC. (US) | 2011-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249195-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | CHRM3, CHRM2, CHRM1 | MAOA 498/4885MAOB 389/4885ATM 2883/4885 |
| US-20130059898-A1 | 7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | CHRM3, CHRM2, CHRM1 | MAOA 601/4885MAOB 366/4885ATM 2401/4885 |
| US-20160296497-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | CHRM3, CHRM2, CHRM1 | MAOA 498/4885MAOB 389/4885ATM 2883/4885 |
| US-20130157989-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | CHRM3, CHRM2, CHRM1 | MAOA 570/4885MAOB 385/4885ATM 2945/4885 |
| US-20120029044-A1 | 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF | CHRM3, CHRM2, CHRM1 | MAOA 570/4885MAOB 385/4885ATM 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.